Michael Roberts
Keine laufenden Positionen mehr
Vermögen: 2 Mio $ am 31.05.2024
Profil
Michael J.
Roberts worked as a Director of Business Development at Nektar Therapeutics and Embarcadero Technologies, Inc. He was also a Manager of Biopharmaceutical Research at Shearwater Corp.
From 2010 to 2014, he served as Vice President of Business Development at Chelsea Therapeutics International Ltd.
Roberts holds a doctorate from The University of Alabama and an undergraduate degree from The Pennsylvania State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
TRIFAST PLC
1,54% | 03.06.2024 | 2 100 000 ( 1,54% ) | 2 Mio $ | 31.05.2024 |
Ehemalige bekannte Positionen von Michael Roberts
| Unternehmen | Position | Ende |
|---|---|---|
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Corporate Officer/Principal | 23.06.2014 |
Shearwater Corp.
 Shearwater Corp. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Shearwater Corp. is a company that provides research services focused on health care applications of advanced PEGylation. The company is based in Huntsville, AL. The company was founded by James R. Hudson, J. Milton Harris. Shearwater was acquired by Nektar Therapeutics on July 02, 2001 for $164.50 million. | Corporate Officer/Principal | - |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
Embarcadero Technologies, Inc.
 Embarcadero Technologies, Inc. Packaged SoftwareTechnology Services Embarcadero Technologies, Inc. provides tools for application developers and database professionals. Its products include application development software, RAD studio, delphi, C++builder and interbase. The company was founded in 1993 and is headquartered in Austin, TX. | Direktor/Vorstandsmitglied | - |
Ausbildung von Michael Roberts
| The University of Alabama | Doctorate Degree |
| The Pennsylvania State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Embarcadero Technologies, Inc.
Embarcadero Technologies, Inc. Packaged SoftwareTechnology Services Embarcadero Technologies, Inc. provides tools for application developers and database professionals. Its products include application development software, RAD studio, delphi, C++builder and interbase. The company was founded in 1993 and is headquartered in Austin, TX. | Technology Services |
Chelsea Therapeutics International Ltd.
 Chelsea Therapeutics International Ltd. BiotechnologyHealth Technology Chelsea Therapeutics International Ltd. acquires, develops and commercializes innovative products for the treatment of a variety of human diseases. The company was founded by Simon C. Pedder on June 17, 2005 and is headquartered in Charlotte, NC. | Health Technology |
Shearwater Corp.
Shearwater Corp. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Shearwater Corp. is a company that provides research services focused on health care applications of advanced PEGylation. The company is based in Huntsville, AL. The company was founded by James R. Hudson, J. Milton Harris. Shearwater was acquired by Nektar Therapeutics on July 02, 2001 for $164.50 million. | Health Technology |
